AzTrials
AzTrials

Any Injury or Illness Acutely Impacting WorkNCT05146349

Minnesota RETAIN Impact Evaluation

A study testing Minnesota RETAIN in people with Any Injury or Illness Acutely Impacting Work, run by Mathematica Policy Research, Inc. at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Minnesota RETAIN
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,200 participants
Where
1 siteUnited States
Study dates
23 Dec 2021to 28 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Must have been unable to work for no more than 6 months prior enrollment; 80% of participants must be within 3 months of their last day of work
  • 18 years or older
  • Minnesota resident
  • Works in Minnesota
  • Employed or currently in the labor force
  • Meets one of the following:
  • Diagnosis of a work related or personal injury or illness that impacts employment
  • Invasive procedure (e.g., surgery) within the past 12-weeks or anticipated within the next 8-weeks that impacts employment

Who cannot join

  • Legal representation/litigation at the time of enrollment related to their medical condition.
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e. Mayo Clinic employees)
  • Worker's compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)

Trial locations and contacts

1 site in 1 country.

Catherine Turvey, MPH contact

734-205-3145

cturvey@mathematica-mpr.com

United States1 site, 1 recruiting
  • Mn Retain, Mayo Clinic

    Rochester, Minnesota, 55905

    Samantha Westphal, RN, BSN, PHN, CLMS, 507-284-4537, retain@mayo.edu

    Tammy Green, MBA, 507-768-5275, green.my@mayo.edu

    Recruiting

Other trials in United States

About this study

Official title: One-Year Impact Evaluation of Minnesota Retaining Employment and Talent After Injury/Illness Network (RETAIN)

This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. Collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay at work and return to work will be implemented.

Read the detailed description

MN RETAIN is a collaborative program led by the Minnesota Department of Employment and Economic Development (DEED), Minnesota Department of Health (MDH), Department of Labor and Industry (DLI), Mayo Clinic, and Workforce Development Inc (WDI) and includes stakeholders throughout MN.

Being tested
Minnesota RETAIN
Keywords
RETAIN, Minnesota RETAIN, MN RETAIN, illness recovery, injury recovery, out of work help, work placement assistance, job help, work help, help keeping my job, stay at work, return to work

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Minnesota RETAINOther

    RETAIN projects include a combination of medical provider services, stay-at-work/return-to-work (SAW/RTW) coordination services, and other SAW/RTW services. The evaluation compares the treatment group that is eligible to receive the full set of RETAIN intervention activities and an control group that is not.

Study groups in NCT05146349
Study groupRoleWhat they receive
RETAIN ProgrammingExperimentalThe experimental group receives the full set of RETAIN intervention activities.
Receives: Other: Minnesota RETAIN
ControlNo interventionThe control group does not receive the full set of RETAIN intervention activities.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Share of enrollees employed in the fourth quarter after enrollment

    Share of enrollees employed in the fourth quarter after enrollment obtained from state unemployment insurance wage records. These files include individual-level wage records for six quarters surrounding enrollment in the study, including the quarter prior to enrollment, the quarter of enrollment, and four post-enrollment quarters.

    Measured: Measured in the fourth quarter after enrollment

  2. Enrollee earnings in the fourth quarter after enrollment

    Sum of enrollee earnings in the fourth quarter after enrollment obtained from state unemployment insurance wage records. These files include individual-level wage records for six quarters surrounding enrollment in the study, including the quarter prior to enrollment, the quarter of enrollment, and four post-enrollment quarters.

    Measured: Measured in the fourth quarter after enrollment

  3. Share of enrollees that applied for SSDI or SSI during the 12 months after enrollment

    Share of enrollees that applied for SSDI or SSI during any of the 12 months after enrollment obtained from SSA program data. These files include detailed information about Social Security Disability Insurance (SSDI) and Supplemental Security Income (SSI) applications SSDI and SSI awards, SSDI and SSI benefit amounts and enrollee characteristics (for enrollees who have ever applied for SSA program benefits)

    Measured: Measured in the 12 months after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2021
  2. Study start23 Dec 2021
  3. Primary completionJun 2025 (estimated)
  4. Study completion28 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
3,200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05146349
Sponsor's protocol ID
RTN-MN
Other IDs
OD-32543-18-75-4-27
Status last verified
Nov 2021
First submitted
23 Nov 2021
Last updated
24 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Minnesota RETAIN in people with Any Injury or Illness Acutely Impacting Work, run by Mathematica Policy Research, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Amaka Osuoha, MPH (734-205-3085, aosuoha@mathematica-mpr.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Share of enrollees employed in the fourth quarter after enrollment (time frame: Measured in the fourth quarter after enrollment). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in